Eb Haus Austria Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH

Salzburg 8 trials 3 recruiting

8 Registered trials

3 Currently recruiting

Organisation

Eb Haus Austria Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH

Location

Salzburg, Austria

Identifier

ORG-100014484

Address

Müllner Hauptstraße 48, 5020, Austria

Departments

Center for Clinical Cancer and Immunology Trials
Department of Dermatology and Allergology, EB Haus Austria
Department of paediatrics
EB House Austria
EB-Haus Austria, Universitätsklinik für Dermatologie und Allergologie
Hematology and Oncology
Medical Oncology
Universitätsklinik für Kinder- und Jugendheilkunde

Clinical trials at this site (8)

Search interface

Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-… Recruiting

2025-520982-39-00 Philadelphia Chromosome Positive or ABL-class Philadelp 5 2025-12-09
Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Recessive Dystrophic Epidermolysis Bullosa(RDEB) and Ju 5 2023-06-13
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study with Open-Label Extension Evalu… Recruiting

2023-508818-42-00 Generalized Epidermolysis Bullosa Simplex (EBS) 10 2024-05-21
A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant trea… Ended

2023-510357-42-00 hormone receptor (HR)-positive, HER2-negative, early br 5 2019-05-22
A Study of TAK-676 as Single Agent and TAK-676 in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Ended

2023-505627-30-00 Solid Neoplasm 7 2023-07-26
NIHR127468 - The GHD Reversal Trial Ended

2022-502008-62-00 Growth Hormone Deficiency (GHD) 5 2023-05-17
A study of Ibrutinib in combination with Rituximab versus Placebo in combination with Rituximab in treatment of patients with Follicular Lym… Ended

2023-507271-21-00 Follicular Lymphoma 5 2017-04-11
Rigosertib for RDEB-SCC Ended

2024-518846-25-00 Recessive Dystrophic Epidermolysis bullosa associated 4